New Zealand - English - Ministry for Primary Industries

bayer new zealand limited - indaziflam - suspension concentrate - indaziflam 500 g/litre - herbicide - herbicide

United States - English - NLM (National Library of Medicine)

unither manufacturing llc - hydrocodone (unii: 6yks4y3wq7) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine (unii: 3u6io1965u) (chlorpheniramine - unii:3u6io1965u) - hydrocodone bitartrate 10 mg in 5 ml - tussionex pennkinetic extended-release suspension is indicated for relief of cough and upper respiratory symptoms associated with allergy or a cold in adults and children 6 years of age and older. tussionex pennkinetic extended-release suspension is contraindicated in patients with a known allergy or sensitivity to hydrocodone or chlorpheniramine. the use of tussionex pennkinetic extended-release suspension is contraindicated in children less than 6 years of age due to the risk of fatal respiratory depression. tussionex pennkinetic extended-release suspension is a schedule ii narcotic. psychic dependence, physical dependence and tolerance may develop upon repeated administration of narcotics; therefore, tussionex pennkinetic extended-release suspension should be prescribed and administered with caution. however, psychic dependence is unlikely to develop when tussionex pennkinetic extended-release suspension is used for a short time for the treatment of cough. physical dependence, the condition in which contin

United States - English - NLM (National Library of Medicine)

ucb inc. - hydrocodone (unii: 6yks4y3wq7) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine (unii: 3u6io1965u) (chlorpheniramine - unii:3u6io1965u) - hydrocodone 10 mg in 5 ml - tussionex pennkinetic extended-release suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use: - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve tussionex pennkinetic for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. tussionex pennkinetic is contraindicated for: - all children younger than 6 years of age [see warnings and precautions (5.2, 5.3), use in specific populations (8.4) ]. tussionex pennkinetic is also contraindicated in patients with: -

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ademetionine - oral tablet - 200mg

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 38473 - information system, patient record - information system for patient records

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

momentive performance materials inc. - trisiloxane ethoxylate - liquid - trisiloxane ethoxylate emulsifiers & surfactants-noni active 500.0 g/l - adjuvant - foliar nutrients additive | fungicide additive | growth regulator additive | insecticide additive | low volume application | ret - carrier - anti-evaporant | horticultural tree crops | spreading agent | vegetable - refer to label | vines - refer to label | wetting agent (use as directed) | adjuvant | apples | avocadoes | citrus | evaporant | herbicide application | improve penetrating properties | insecticide application | mangoes | olives | wetter

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - clobetasol propionate, quantity: 0.05 % w/v - application - excipient ingredients: polyquaternium-10; ethanol; purified water; citric acid monohydrate; coco-betaine; sodium laureth sulfate; sodium citrate dihydrate - topical treatment of moderate to severe scalp psoriasis in adults.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmatrade germany - 1 software application [pwd (08758905) & hcp (08888353)] - software - application software - medical devices-medical devices